Editorial comment

Urology. 2010 May;75(5):1143. doi: 10.1016/j.urology.2009.12.055.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Androgen Antagonists / therapeutic use
  • Bone Density Conservation Agents / therapeutic use*
  • Bone Diseases, Metabolic / etiology
  • Bone Diseases, Metabolic / prevention & control*
  • Diphosphonates / therapeutic use*
  • Gonadotropin-Releasing Hormone / analogs & derivatives
  • Humans
  • Imidazoles / therapeutic use*
  • Male
  • Orchiectomy
  • Osteoporosis / etiology
  • Osteoporosis / prevention & control*
  • Prostatic Neoplasms / therapy*
  • Severity of Illness Index
  • Zoledronic Acid

Substances

  • Androgen Antagonists
  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Gonadotropin-Releasing Hormone
  • Zoledronic Acid